A5016042133- Coronary Interventions and Diagnostics
- Cardiac Imaging and Diagnostics
- Acute Myocardial Infarction Research
- Peripheral Artery Disease Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Vascular Procedures and Complications
- Cardiac Structural Anomalies and Repair
- Cardiovascular Function and Risk Factors
- Venous Thromboembolism Diagnosis and Management
- Mechanical Circulatory Support Devices
- Cardiac Valve Diseases and Treatments
- Atrial Fibrillation Management and Outcomes
- Cardiac, Anesthesia and Surgical Outcomes
- Cerebrovascular and Carotid Artery Diseases
- Cardiac Arrest and Resuscitation
- Cardiac pacing and defibrillation studies
- Aortic aneurysm repair treatments
- Cardiac Arrhythmias and Treatments
- Cardiovascular Issues in Pregnancy
- COVID-19 Clinical Research Studies
- Cardiac electrophysiology and arrhythmias
- Advanced MRI Techniques and Applications
- Central Venous Catheters and Hemodialysis
- Cardiovascular Health and Disease Prevention
- Heart Failure Treatment and Management
Liverpool Hospital
2016-2025
UNSW Sydney
2014-2024
Prince of Wales Hospital
2024
South Western Sydney Local Health District
2010-2023
Gold Coast Health
2023
Ingham Institute
2020-2023
Royal North Shore Hospital
2023
Western Sydney University
2022
Camden and Campbelltown Hospitals
2021
Virginia Commonwealth University
2021
The use of a retrograde approach and algorithm-driven CTO (chronic total occlusion) percutaneous coronary intervention (PCI) has become widespread, many registries have reported good results. This study established new algorithm applied it to current practice collected registry document the It compared outcomes versus antegrade in contemporary multicentre registry.Between 1 January 2016 31 December 2016, consecutive patients who underwent PCI performed by eight high-volume operators were...
Periprocedural myocardial infarction (PMI) has had several definitions in the last decade, including Society for Cardiovascular Angiography and Interventions (SCAI) definition, that requires marked biomarker elevations congruent with surgical PMI criteria.
Left ventricular (LV) thrombus is a complication of acute ST-segment elevation myocardial infarction (STEMI). We determined the incidence and predictors LV formation using serial cardiac magnetic resonance (CMR) two-dimensional echocardiography studies. Two hundred ten patients underwent CMR (median 4 days [IQR 3-7]) transthoracic early after STEMI presentation with follow-up 55 46-64]) studies 54 45-64]) performed subsequently. The was 12.3% (26/210) by 6.2% (13/210) echocardiography....
Abstract Aims Pharmaco-invasive percutaneous coronary intervention (PI-PCI) is recommended for patients with ST-elevation myocardial infarction (STEMI)who are unable to undergo timely primary PCI (pPCI). The present study examined late outcomes after PI-PCI (successful reperfusion followed by scheduled or failed and rescue PCI)compared pPCI (>120 min from first medical contact). Methods results All STEMI presenting within 12 h of symptom onset, who underwent during their initial...
Background & AimRobotic-assisted percutaneous coronary intervention (R-PCI) has been increasingly performed overseas. Initial observations have demonstrated its clinical efficacy and safety with additional potential benefits of more accurate lesion assessment stent deployment, reduced radiation exposure to operators patients. However, data from randomised controlled trials or experience Australia are lacking.MethodsThis was a single-centre all patients undergoing R-PCI as part the run-in...
Abstract We assessed patient tolerance and resource utilization of using the AngioSeal closure device versus assisted manual compression Femostop after percutaneous coronary intervention (PCI). Patients undergoing PCI with clean arterial access no procedural hematoma were randomized to receive or achieve femoral hemostasis. Times from procedure end removal angiography table, hemostasis, ambulation, hospital discharge recorded. Bedside nursing/medical officer care time, vascular...
The use of contrast agents during coronary intervention can result in nephropathy, particularly patients with renal dysfunction. We aimed to determine whether the iso-osmolar iodixanol is less nephrotoxic than that low-osmolar iopromide when are adequately prehydrated and have received N-acetylcysteine.We conducted a randomized, double-blind, multicentre study impaired function undergoing interventional procedure. Primary end-point was incidence contrast-induced nephropathy (CIN) on day 2,...
Background: Coronary microvascular dysfunction after acute coronary syndrome is an important predictor of long-term prognosis. Data lacking on the effects oral P2Y 12 -inhibitors function in non–ST-segment–elevation syndrome. The aim this study was to compare ticagrelor versus clopidogrel pretreatment patients. Methods: Hospitalized patients were randomized (1:1) or clopidogrel. index microcirculatory resistance, flow reserve, and resistive reserve ratio obtained using intracoronary...
Abstract Antegrade dissection reentry with Stingray device (Boston Scientific, Marlborough, MA) accounts for 20–34% of the chronic total occlusion (CTO) cases in various hybrid operators' CTO registries and is an important component crossing algorithms. The can facilitate antegrade reentry, however its use low outside North America Europe. Asia Pacific Club along three experience operators from US, Europe India, created algorithm guiding CrossBoss catheter. This APCTO defines when to...
ObjectivesDescribe the incidence of cardiac complications in patients admitted to hospital with COVID-19 Australia.DesignObservational cohort study.SettingTwenty-one (21) Australian hospitals.ParticipantsConsecutive aged ≥18 years laboratory confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.Main outcome measuresIncidence complications.ResultsSix-hundred-and-forty-four (644) hospitalised (62.5±20.1 yo, 51.1% male) were enrolled study. Overall in-hospital...